Aktuellt
SENASTE
At SEB’s Nordic Seminar, CEO Anders Göransson presented Bactiguard, including an upbeat picture of the long-term prospects for growth, with the option of new licence deals on top. With recent expansion of opportunities (e.g. the expansion deal with Zimmer Biomet) and with recent increases to opex, Bactiguard will now enter delivery mode with most prerequisites in place. Its ambition of reaching SEK 1bn in net sales by 2026 was reiterated (expanding from SEK 227m LTM).
LÄS MER
